Nitrogen-containing aromatic derivatives

Details Nitrogen-containing aromatic derivatives Nitrogen-containing aromatic derivatives

2005-12-02

2009-11-03

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S153000, C546S155000

Reexamination Certificate

active

07612092

ABSTRACT:
Compounds represented by the following general formula:[wherein Agis an optionally substituted 5- to 14-membered heterocyclic group, etc.; Xgis —O—, —S—, etc.; Ygis an optionally substituted C6-14aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and Tg1is a group represented by the following general formula:(wherein Egis a single bond or —N(Rg2)—, Rg1and Rg2each independently represent a hydrogen atom, an optionally substituted C1-6alkyl group, etc. and Zgrepresents a C1-8alkyl group, a C3-8alicyclic hydrocarbon group, a C6-14aryl group, etc.)], salts thereof or hydrates of the foregoing.

REFERENCES:
patent: 4764454 (1988-08-01), Ichijima et al.
patent: 7253286 (2007-08-01), Funahashi et al.
patent: 0 870 842 (1998-10-01), None
patent: 1 153 920 (2001-11-01), None
patent: 1698623 (2006-09-01), None
patent: 1797881 (2007-06-01), None
patent: 04-341454 (1994-06-01), None
patent: 8048078 (A) (1996-02-01), None
patent: 07-176103 (1997-01-01), None
patent: 08-045927 (1997-09-01), None
patent: 11-158149 (1999-06-01), None
patent: 11-143429 (2000-11-01), None
patent: 3712393 (2005-11-01), None
patent: 2006-515884 (2006-06-01), None
patent: WO 97/17329 (1997-05-01), None
patent: WO-98/000134 (1998-01-01), None
patent: WO 98/37079 (1998-08-01), None
patent: WO 99/00357 (1999-01-01), None
patent: WO-99/032106 (1999-07-01), None
patent: WO-99/032436 (1999-07-01), None
patent: WO-00/042012 (2000-07-01), None
patent: WO 00/43366 (2000-07-01), None
patent: WO 01/45689 (2001-06-01), None
patent: WO 01/47890 (2001-07-01), None
patent: WO 01/47931 (2001-07-01), None
patent: WO2004/064730 (2004-08-01), None
patent: WO2004/080462 (2004-09-01), None
patent: WO2004/080966 (2004-09-01), None
patent: WO2004/101526 (2004-11-01), None
Bellone, et al., “Growth Stimulation of Colorectal Carcinoma Cells via the c-kit Receptor is Inhibited by TGF-β-1”,Journal of Cellular Physiology, 172: 1-11, 1997.
Berdel, et al., “Recombinant Human Stem Cell Factor Stimulates Growth of a Human Glioblastoma Cell Line Expressing c-kit Protooncogene”,Cancer Research, 52: 3498-3502, 1992.
Bussolino, et al., “Role of Soluble Mediators in Angiogenesis”Eur. J. Cancer, 32A(14): 2401-2412, 1996.
Cohen, et al., “Expression of Stem Cell Factor and c-kit in Human Neuroblastoma”,Blood, 84(10): 3465-3472, 1994.
Deplanque, et al., “Anti-Angiogenic Agents: Clinical Trial Design and Therapies in Development”,European Journal of Cancer, 36: 1713-1724, 2000.
Folkman, J., “New Perspective in Clinical Oncology From Angiogenesis Research”,Eur J. Cancer. 32A(14): 2534-2539, 1996.
Folkman, et al., “Angiogenesis”,The Journal of Biological Chemistry, 267(16): 10931-10934, 1992.
Folkman, et al., “Clinical Applications of Research on Angiogenesis”,The New England Journal of Medicine, 333(26): 1757-1763, 1995.
Folkman, J., “What is the Evidence that Tumors are Angiogenesis Dependent?”,Journal of the National Cancer Institute, 82(1): 4-6, 1990.
Furitsu, et al., “Identification of Mutations in the Coding Sequence of the Proto-Oncogenec-kitin a Human Mast Cell Leukemia Cell Line Causing Ligand-Independent Activation ofc-kitProduct”J. Clin. Invest.92: 1736-1744, 1993.
Furuta, et al., “Synthesis and Biological Evaluation of Selective Inhibitors of PDGF Receptor Auto Phosphorylation”Pharmaceutical Research Laboratories, Kirin Brewery Co., Ltd., Takasaki, Gunma, Japan.
Golkar, et al., “Mastocytosis”,Lancet, 349: 1379-1385, 1997.
Hamel, et al., The Road Less Travelled:c-kitand Stem Cell Factor,Journal of Neuro-Oncology, 35:327-333, 1997.
Hibi, et al., “Coexpression of the Stem Cell Factor and thec-kitGenes in Small-Cell Lung Cancer”,Oncogene, 6: 2291-2296, 1991.
Hines, et al., “Coexpression of the c-kit and Stem Cell Factor Genes in Breast Carcinomas”,Cell Growth&Differentiation, 6: 769-779, 1995.
Hogaboam, et al., “Novel Role of Transmembrane SCF for Mast Cell Activation and Eotaxin Production in Mast Cell-Fibroblast Interactions”,The Journal of Immunology, 160: 6166-6171, 1998.
Ikeda, et al., “Changes in Phenotype and Proliferative Potential of Human Acute Myeloblastic Leukemia Cells in Culture with Stem Cell Factor”,Experimental Hematology, 21: 1686-1694, 1993.
Ikeda, et al., “Expression and Functional Role of the Proto-Oncogenec-kitin Acute Myeloblastic Leukemia Cells”,Blood, 78(11): 2962-2968, 1991.
Blume-Jensen, et al., “Activation of the Humanc-kitProduct by Ligand-Induced Dimerization Mediates Circular Actin Reorganization and Chemotaxis”,The EMBO Journal, 10(13): 4121-4128, 1991.
Kanakura, et al., “Expression, Function and Activation of the Proto-Oncogene c-kit Product in Human Leukemia Cells”,Leukemia and Lymphoma, 10: 35-41, 1993.
Kay, et al., “Eosinophils and Eosinophil-Associated Cytokines in Allergic Inflammation”,Int. Arch. Allergy Immunol.113: 196-199, 1997.
Kitamura, et al., “Regulation of Development, Survival and Neoplastic Growth of Mast Cells through thec-kitReceptor”,Int Arch Allergy Immunol., 107: 54-56, 1995.
Kolibaba, et al., “Protein Tyrosine Kinases and Cancer”,Biochimica et Biophysica Acta, 1333: F217-F248, 1997.
Kotva, et al., “Substances with Antineoplastic Activity, LIII. N-(δ-(4-Pyrrolo[2,3-d]Pyrimidinylthio) Valeryl) Amino Acids and Analogous Derivatives of Di-and Triglycine”,Collection Czechoslov. Chem. Commun.38: 1438-1444, 1973.
Lasota, et al., “Mutations in Exons 9 and 13 of KIT Gene Are Rare Events in Gastrointestinal Stromal Tumors”,American Journal of Pathology, 157(4): 1091-1095, 2000.
Lev, et al., “A Specific Combination of Substrates is Involved in Signal Transduction by the Kit-Encoded Receptor”,The EMBO Journal, 10(3): 647-654, 1991.
Longley, et al., “Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis”,The New England Journal of Medicine, 328(18): 1302-1307, 1993.
Longley, et al., “Somatic c-KIT Activating Mutation in Urticaria Pigmentosa and Aggressive Mastocytosis: Establishment of Clonality in a Human Mast Cell Neoplasm”,Nature Genetics, 12: 312-314, 1996.
Lukacs, et al., “Stem Cell Factor (c-kitLigand) Influences Eosinophil Recruitment and Histamine Levels in Allergic Airway Inflammation”,The Journal of Immunology, 156: 3945-3951, 1996.
Meltzer, E.O., “The Pharmacological Basis for the Treatment of Perennial Allergic Rhinitis and Non-Allergic Rhinitis with Topical Corticosteroids”,Allergy, 52: 33-40, 1997.
Metcalfe, D., “Classification and Diagnosis of Mastocytosis:Current Status”, J. Invest. Dermatol, 96: 2S-4S, 1991.
Metcalfe, et al., “Mast Cells”,Physiological Reviews, 77(4): 1033-1079, 1997.
Metcalf, et al., “Lineage Commitment in the Progeny of Murine Hematopoietic Preprogenitor Cells: Influence of Thrombopoietin and Interleukin 5”,Proc. Nat'l Acad. Sci. USA, 95: 6408-6412, 1998.
Naclerio, et al., “Rhinitis and Inhalant Allergens”,JAMA, 278(22): 1842-1848, 1997.
Nagata, et al., “Elevated Expression of the Proto-Oncogene c-kit in Patients with Mastocytosis”,Leukemia, 12: 175-181, 1998.
Natali, et al., “Breast Cancer is Associated with Loss of thec-kitOncogene Product”,Int. J. Cancer, 52: 713-717, 1992.
Okayama, et al., “Activation of Eosinophils with Cytokines Produced by Lung Mast Cells”,Int Arch Allergy Immunol.114:(suppl 1): 75-77, 1997.
Okayama, et al., “Human Lung Mast Cells are Enriched in the Capacity to Produce Granulocyte-Macrophage Colony-Stimulating Factor in Response to IgE-Dependent Stimulation”,Eur. J. Immunol.28: 708-715, 1998.
Scheijen, et al., “Tyrosine Kinase Oncogenes in Normal Hematopoiesis and Hematological Disease”,Oncogene, 21: 3314-3

Affiliated with

Also associated with

Rating

Nitrogen-containing aromatic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitrogen-containing aromatic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing aromatic derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4119312